Teladoc Health (NYSE:TDOC) Releases FY 2026 Earnings Guidance

Teladoc Health (NYSE:TDOC) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of -1.050–0.750 for the period, compared to the consensus estimate of -0.930. The company issued revenue guidance of $2.5 billion-$2.6 billion, compared to the consensus revenue estimate of $2.5 billion. Teladoc Health also updated its Q2 2026 guidance to -0.300–0.200 EPS.

Analyst Ratings Changes

Several brokerages have issued reports on TDOC. Stifel Nicolaus decreased their price objective on shares of Teladoc Health from $8.00 to $6.00 and set a “hold” rating for the company in a research note on Thursday, February 26th. Citigroup reduced their target price on shares of Teladoc Health from $9.00 to $6.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 3rd. Oppenheimer reduced their target price on shares of Teladoc Health from $12.00 to $7.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 3rd. Canaccord Genuity Group reduced their target price on shares of Teladoc Health from $12.00 to $10.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Finally, Bank of America raised shares of Teladoc Health from a “neutral” rating to a “buy” rating and set a $7.00 target price on the stock in a research report on Thursday, February 26th. Five analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $7.47.

Teladoc Health Stock Up 1.4%

TDOC stock traded up $0.09 during trading on Friday, hitting $6.15. 951,806 shares of the company’s stock traded hands, compared to its average volume of 5,909,879. The firm has a market capitalization of $1.11 billion, a P/E ratio of -6.38 and a beta of 2.07. The business has a fifty day simple moving average of $5.40 and a two-hundred day simple moving average of $6.46. The company has a quick ratio of 2.67, a current ratio of 2.77 and a debt-to-equity ratio of 0.72. Teladoc Health has a 1 year low of $4.40 and a 1 year high of $9.77.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.02). Teladoc Health had a negative return on equity of 11.32% and a negative net margin of 6.81%.The firm had revenue of $613.85 million during the quarter, compared to analysts’ expectations of $610.87 million. During the same period in the prior year, the firm posted ($0.53) earnings per share. Teladoc Health’s revenue for the quarter was down 2.5% compared to the same quarter last year. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. Sell-side analysts anticipate that Teladoc Health will post -0.89 EPS for the current year.

Insider Transactions at Teladoc Health

In other Teladoc Health news, CEO Charles Divita III sold 27,731 shares of Teladoc Health stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $5.49, for a total value of $152,243.19. Following the transaction, the chief executive officer directly owned 364,784 shares of the company’s stock, valued at approximately $2,002,664.16. The trade was a 7.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

Institutional investors and hedge funds have recently bought and sold shares of the company. IFP Advisors Inc grew its holdings in Teladoc Health by 412.1% in the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after purchasing an additional 3,210 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in Teladoc Health by 177.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after purchasing an additional 2,810 shares during the last quarter. Van ECK Associates Corp grew its holdings in Teladoc Health by 101.4% in the fourth quarter. Van ECK Associates Corp now owns 9,150 shares of the health services provider’s stock worth $64,000 after purchasing an additional 4,607 shares during the last quarter. Johnson Financial Group Inc. grew its holdings in Teladoc Health by 41,045.8% in the third quarter. Johnson Financial Group Inc. now owns 9,875 shares of the health services provider’s stock worth $76,000 after purchasing an additional 9,851 shares during the last quarter. Finally, Cibc World Markets Corp purchased a new position in Teladoc Health in the fourth quarter worth $82,000. 76.82% of the stock is owned by hedge funds and other institutional investors.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.